Immune diseases and cancer are among the most severe pathologies that affect patients treated at the CHU Sainte-Justine. The CHU Sainte-Justine is responsible for the diagnosis and treatment of more than 65% of pediatric cancers in Quebec. Our institution is the only accredited pediatric bone marrow transplantation centre and the only one to perform all types of solid organ transplants in Quebec..
Also, the CHU Sainte-Justine is one of the world leaders for research and management of patients with immune diseases and cancer. To address the medical issues related to immune disorders and cancer, the axis has strategically prioritized research in hematopoietic malignancies as well as functional genomics and cell/gene therapy. Some of the most innovative experimental approaches in cellular and molecular biology and bioinformatics are used to resolve research issues related to these disorders.
The three strategic themes incorporate fundamental, applied and clinical studies in order to clarify the origins of these pathologies, thereby improving the transfer of knowledge for diagnosis, prognosis and/or treatment.
The axis favors a pluridisciplinary approach with expertise in genetics, epidemiology, pharmacogenetics, biostatistics, oncology, physiology/cell biology, genomics, proteomics, bioinformatics, immunology, gene therapy, pharmacology, nutrition, biochemistry, pathology, molecular biology, virology, hepatology, microbiology, gastroenterology, and surgery.